Healthcare Roundup – FDA OKs emergency use of Philips monitors for COVID-19 use, AgeX Therapeutics +12% on ESI 053 deal for COVID-19 Life Science
Technology Roundup – Wells Fargo sees big upside in Microsoft, Online retail stocks continue to sizzle Technology
Healthcare Roundup – FDA OKs emergency use of Siemens COVID-19 blood test, Short regimen of Gilead’s remdesivir beats standard-of-care in COVID-19 study Life Science
Technology Roundup – Amazon rally expected to extend as online dominates, WarnerMedia names new chief technology officer Technology
Healthcare Roundup – Gilead not quite there with remdesivir nod in Europe, Chi-Med’s NDA for savolitinib accepted in China Life Science
Technology Roundup – Pair of U.S.-listed China ADRs to list shares in Hong Kong, Trump vs. Twitter war escalates further Technology
Technology Roundup – Trump signs executive order targeting social media, Cisco nearing $1B deal for ThousandEyes Technology
Healthcare Roundup – Roche launches new studies of Actemra + remdesivir, CVS Health to achieve 1,000 COVID-19 sample collection sites Life Science
Healthcare Roundup – PhaseBio gets FDA OK for clinical trial of COVID-19 treatment, Moderna correction pressures COVID-19 vaccine developers Life Science
Technology Roundup – President threatens social media companies, Microsoft in talks to buy ~$2B stake in Jio Platforms Technology
Technology Roundup – Amazon in advanced talks to buy Zoox, Alibaba seen outperforming as rapid COVID-19 recovery extends Technology
Healthcare Roundup – Merck jumps into COVID-19 arena with three initiatives, Gilead picks up an upgrade on remdesivir upside Life Science
